Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
暂无分享,去创建一个
B. Hyman | T. Gómez-Isla | K. Newell | E. Hedley‐Whyte | W. Growdon | M. McNamara | E. Gómez-Tortosa | M. McNamara | B.T. Hyman | K. Newell | T. Gómez-Isla | W.B. Growdon | E. Gómez-Tortosa | E.T. Hedley-Whyte
[1] C. Hofstetter,et al. Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density , 1997, Journal of neuropathology and experimental neurology.
[2] P. Ince,et al. A quantitative comparison of plaque types in Alzheimer’s disease and senile dementia of the Lewy body type , 1996, Acta Neuropathologica.
[3] L. Hansen,et al. Criteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies , 1997, Neurology.
[4] P. Ince,et al. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.
[5] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[6] L. Thal,et al. The Lewy body variant of Alzheimer's disease , 1990, Neurology.
[7] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] S. Corkin,et al. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. , 1995, Archives of neurology.
[9] D. Irving,et al. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei , 1990, Journal of the Neurological Sciences.
[10] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[11] J. Polak,et al. Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type , 1992, Neuroscience Letters.
[12] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[13] L. Wolfson,et al. Clinico‐pathologic studies in dementia , 1988, Neurology.
[14] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[15] E. Masliah,et al. Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.
[16] Kevin Cox,et al. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.
[17] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[18] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[19] M. Sliwinski,et al. Pathological markers associated with normal aging and dementia in the elderly , 1993, Annals of neurology.
[20] R. Godwin-Austen,et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[21] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[22] Michael Alford,et al. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies , 1993, Brain Research.
[23] D. Galasko,et al. Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[24] W. Honer,et al. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.
[25] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[26] D. Galasko,et al. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies , 1993, Neurology.
[27] B T Hyman,et al. Kunitz Protease Inhibitor‐Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease , 1992, Journal of neuropathology and experimental neurology.
[28] R. Katzman.,et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.
[29] G. V. Van Hoesen,et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.
[30] C. Duyckaerts,et al. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.
[31] A. Lees,et al. A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.
[32] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[33] E. Masliah,et al. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies , 1991, Neuroscience Letters.